A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data ; volume:27 ; number:4 ; year:2021 ; pages:268-276 ; extent:9
European addiction research ; 27, Heft 4 (2021), 268-276 (gesamt 9)

Urheber
Morin, Kristen A.
Parrotta, Matthiew D.
Eibl, Joseph K.
Marsh, David C.

DOI
10.1159/000513471
URN
urn:nbn:de:101:1-2021070100322493309183
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:49 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Morin, Kristen A.
  • Parrotta, Matthiew D.
  • Eibl, Joseph K.
  • Marsh, David C.

Ähnliche Objekte (12)

Telemedicine: Can In-Person Pre-treatment Communication be Expanded by Video Consultation?

Telemedicine: Can In-Person Pre-treatment Communication be Expanded by Video Consultation?

Better agonist for the opioid receptors

Better agonist for the opioid receptors

Alcohol use in opioid agonist treatment

Alcohol use in opioid agonist treatment

Interim opioid agonist treatment for opioid addiction: a systematic review

Interim opioid agonist treatment for opioid addiction: a systematic review

Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs

Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs

Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic

Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic

Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]

Hochschulschrift

Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Patients’ perspectives and preferences toward telemedicine versus in-person visits: a mixed-methods study on 1226 patients

Patients’ perspectives and preferences toward telemedicine versus in-person visits: a mixed-methods study on 1226 patients

Untersuchungen zur Wirkung des κ-Opioid-Rezeptor-Agonisten [Kappa-Opioid-Rezeptor-Agonisten] EMD 61 753 und Methylprednisolon auf Lymphozyten der Ratte

Hochschulschrift

Untersuchungen zur Wirkung des κ-Opioid-Rezeptor-Agonisten [Kappa-Opioid-Rezeptor-Agonisten] EMD 61 753 und Methylprednisolon auf Lymphozyten der Ratte

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera

Verbundene Objekte